Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. When deadlines turn deadly: examining the psychology of drug regulators
  2. The US and the developing world: a tale of two opioid crises
  3. Covid-19 outbreak: pharma’s big players discuss pandemic response
  4. Covid-19 outbreak: delving into the UK Government’s official action plan
  5. Precision medicine: what barriers remain?

Latest Content

How to launch a drug in a pandemic with Immunomedics

During the ongoing Covid-19 pandemic, the FDA has continued in its normal role of approving safe and effective drugs. But how do pharma companies go about bringing a new drug to market during the pandemic? Immunomedics’ chief commercial officer Brendan Delaney explains how his company has successfully facilitated the treatment of US patients with its first ever drug, Trodelvy, which was approved at the end of April.

Takeda receives China approval for Adcetris to treat lymphoma

Takeda China has received approval from the country's National Medical Products Administration (NMPA) for Adcetris (brentuximab vedotin) to treat relapsed or refractory systemic anaplastic large cell lymphoma (sALCL) or CD30-positive Hodgkin lymphoma in adults.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Close
Close
Close

Go Top